Evidence map›Paper›PMID 31679056›Full record

ArticlePediatric cardiology2020

Implantation of a HeartMate 3 in a 13-Year-Old Child with Dilated Cardiomyopathy.

Raymond Pfister, Matthias Kirsch, Julia Natterer, Stefano Di Bernardo, Rene Pretre

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Raymond PfisterDepartment of Cardiovascular Surgery, Lausanne University Hospital (CHUV), 1011, Lausanne, Switzerland. raymond.pfister@chuv.ch.ORCID http://orcid.org/0000-0002-1465-7914
Matthias KirschDepartment of Cardiovascular Surgery, Lausanne University Hospital (CHUV), 1011, Lausanne, Switzerland.
Julia NattererPaediatric Intensive Care Unit, Department of Paediatrics, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Stefano Di BernardoDepartment of Pediatric Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Rene PretreDepartment of Cardiovascular Surgery, Lausanne University Hospital (CHUV), 1011, Lausanne, Switzerland.
University Hospital of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Left ventricular assist device is a well-established therapy in heart failure adults, but less in children. A 13-year-old-boy with severe left ventricular dysfunction did not improve under medical treatment. A HeartMate 3 (HM3) was implanted as a bridge to transplantation. Despite the size limitation, the HM3 shows promising results and our case supports its feasibility in children.

Indexed as

Heart-Assist DevicesAdolescentCardiomyopathy, DilatedHeart TransplantationHumansMaleVentricular Dysfunction, LeftBridge to transplantHeart failureHeartMate 3LVAD

Identifiers

PMID31679056
OpenAlexW2983938516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.